In this morning's issue of Stock--d's newsletter they give a coverage of Optiscan's current attributes: "Relief of pathologist shortage, Benefits in inttraoperative pathology, Improving diagnosis of oral cancer, Digital pathology will replace the glass slide etc. etc."
Much, if not all has been mentioned here recently, but it's nice to have coverage from an additional source.
Dory, can you upload and post here - sorry, I'm a Luddite in these technical matters.
MM
Good signs ...., page-51
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $100.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.5¢ | 11.5¢ | $80.94K | 672.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3314 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 124429 | 4 |
View Market Depth
| Last trade - 15.43pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.005 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.5¢ | 12.0¢ | 84557 | ||
| Last updated 13.28pm 03/06/2024 ? | |||||
| OIL (ASX) Chart |